sability testing of Minodoronate 50mg for secondary osteoporosis in prostatic caricnoma patients
Phase 2
- Conditions
- secondary osteoporosis in prostatic carcinoma patients
- Registration Number
- JPRN-UMIN000010567
- Lead Sponsor
- rology,Tokyo Medical University,Ibaraki Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
patients using bisphosphonates patients with secondary osteoporosis which cause is not prostatic carcinoma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BMD
- Secondary Outcome Measures
Name Time Method PSA,ICTP,BAP